border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


    • Product Description
  • Once a report has been filed with the SEC it will be available on the website.


    • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this 8-K on 01/11/2010.
    Click on link to view section or document
    1. Entire Document including Exhibit(s)
    2. 8-K
    PAGE: 1 - Steven B. Ratoff President and Chief Executive Officer
    PAGE: 2 - David B. Bergstrom Senior Vice President and Chief Operating Officer
    PAGE: 3 -
    PAGE: 4 - SIGNATURES
    3. EX-10.1 - Material contracts
    PAGE: 1 - 1.3 Location
    PAGE: 2 - 3.4 Employment Taxes
    PAGE: 3 - (ii)
    PAGE: 4 - 4.2 Termination by Mutual Agreement of the Parties
    PAGE: 5 - 4.5.3 Termination For Cause
    PAGE: 6 - 4.5.7 Termination by the Executive for Good Cause
    PAGE: 7 - (iv)
    PAGE: 8 - (iii)
    PAGE: 9 - 4.6.1 Covered Termination
    PAGE: 10 - 4.8 Exclusive Remedy
    PAGE: 11 - 4.10 Survival of Certain Sections
    PAGE: 12 - Exhibit A
    PAGE: 13 - 12. INTERPRETATION; CONSTRUCTION.
    PAGE: 14 - 16. T
    PAGE: 15 - I
    PAGE: 16 - EXHIBIT A
    PAGE: 17 -
    PAGE: 18 - EXHIBIT B
    PAGE: 19 - EXHIBIT C
    4. EX-99.1 - Exhibits not specifically designated by another number and by investment companies
    PAGE: 1 - FORWARD-LOOKING STATEMENTS:




    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer